Literature DB >> 14767721

No nerve growth factor response to treatment with memantine in adult rats.

U E Lang1, M Mühlbacher, M B Hesselink, W Zajaczkowski, W Danysz, H Danker-Hopfe, R Hellweg.   

Abstract

Nerve growth factor (NGF) is the most widely examined neurotrophin in the experimental models of Alzheimer's disease (AD) and has been shown to prevent the retrograde degeneration of cholinergic neurons. In this study we examined NGF and cholineacetyltransferase (ChAT) changes in several rat brain regions after excitotoxic lesion of the entorhinal cortex with quinolinic acid and tested the effect of memantine on spatial learning in the radial maze after lesion. We observed a significant increase (+26%, p=0.02) of NGF concentrations in the hippocampus of the lesioned rats when compared to sham-lesioned rats. Chronic treatment with memantine showed no significant effect on the NGF increase in the hippocampus (p=0.72). The ChAT activity was significantly increased in the lesioned rats when compared to controls (+16%, p<0.05) and did not depend on treatment with memantine. In spite of this, memantine improved performance of the radial maze. This indicates that memory improving effects of memantine observed in experimental animals and in clinical studies are probably not related to changes in brain NGF content, whereas the observed NGF increase in the denervated hippocampus is probably trauma-related reflecting impaired retrograde transport of hippocampal NGF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14767721     DOI: 10.1007/s00702-003-0090-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  7 in total

1.  The effect of memantine on functional recovery of the facial nerve after crush injury.

Authors:  Murat Topdag; Deniz Ozlem Topdag; Kadri Ila; Bahar Muezzinoglu; Busra Yaprak; Murat Ozturk; Sebla Caliskan; Mete Iseri
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02       Impact factor: 2.503

Review 2.  Anti-dementia drugs and hippocampal-dependent memory in rodents.

Authors:  Carla M Yuede; Hongxin Dong; John G Csernansky
Journal:  Behav Pharmacol       Date:  2007-09       Impact factor: 2.293

3.  Long-term treatment of l-3-n-butylphthalide attenuated neurodegenerative changes in aged rats.

Authors:  Shiping Ma; Shaofeng Xu; Bin Liu; Jiang Li; Nan Feng; Ling Wang; Xiaoliang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-02-12       Impact factor: 3.000

4.  Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Hongxin Dong; Carla M Yuede; Carolyn Coughlan; Brian Lewis; John G Csernansky
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

5.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

Review 6.  Neurotrophic factors in Alzheimer's disease: role of axonal transport.

Authors:  K Schindowski; K Belarbi; L Buée
Journal:  Genes Brain Behav       Date:  2008-02       Impact factor: 3.449

7.  Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer's Disease.

Authors:  Simon Couly; Morgane Denus; Mélanie Bouchet; Gilles Rubinstenn; Tangui Maurice
Journal:  Int J Neuropsychopharmacol       Date:  2021-02-15       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.